Clinical Trials Logo

Filter by:
NCT ID: NCT01097707 Terminated - Clinical trials for Benign Prostatic Hyperplasia

A Study in Men With Benign Prostatic Hyperplasia

Start date: April 2010
Phase: Phase 2
Study type: Interventional

The purpose of the study is to determine whether LY500307 helps symptoms of Benign Prostatic Hyperplasia (BPH)

NCT ID: NCT01095250 Terminated - Uveitis Clinical Trials

Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis

INSURE
Start date: April 2010
Phase: Phase 3
Study type: Interventional

This study will assess the safety and efficacy of AIN457 as adjunctive therapy for the treatment of intermediate uveitis, posterior uveitis, or panuveitis requiring systemic immunosuppression.

NCT ID: NCT01095237 Terminated - Clinical trials for Peripheral Arterial Disease

Clinical Pilot-Study of ProEndoTecc Vascular Grafts as Superficial Femoral Artery Bypass / Interponate

Start date: March 2010
Phase: N/A
Study type: Interventional

This is a multi-center, clinical pilot-study of ProEndoTecc Vascular Grafts (6, 7 or 8 mm Diameter) as superficial femoral artery bypass/interponate. The aim of this study is to demonstrate safety of implantation, patency and durability of a new type of vascular graft.

NCT ID: NCT01093846 Terminated - Uveitis Clinical Trials

38 Week Extension Study to CAIN457C2303

SHIELD
Start date: March 2010
Phase: Phase 3
Study type: Interventional

A 38-week extension to a 24 week multicenter, randomized, double-masked, placebo controlled study to assess the difference in the rate of recurrent exacerbations in Behçet's patients with posterior or panuveitis treated with AIN457 vs placebo adjunctive to standard-of-care immunosuppressive therapy

NCT ID: NCT01092858 Terminated - Hypogonadism Clinical Trials

NEBIDO in Symptomatic Late Onset Hypogonadism (SLOH)

Start date: September 2010
Phase: Phase 4
Study type: Interventional

The design of the study is a standard double-blind design, which is needed in this study to allow for unbiased evaluation of efficacy and safety. The effect of the additional impact of testosterone replacement therapy in hypogonadal men on muscle strength and quality of life in comparison to physical exercise alone will be assessed. Treatment duration will be 54 weeks, to monitor the increase as well as the "steady state" of the parameters assessed.

NCT ID: NCT01090310 Terminated - Clinical trials for Non-infectious Uveitis

Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis

ENDURE
Start date: August 2010
Phase: Phase 3
Study type: Interventional

This extension study will assess the safety and efficacy of AIN457 versus placebo for maintaining uveitis suppression when reducing systemic immunosuppression

NCT ID: NCT01089075 Terminated - Clinical trials for Partial Corticotrope Insufficiency

Neuropsychological Effects of Hydrocortisone in Patients With Partial Adrenal Insufficiency

CSMünchen01
Start date: February 2010
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the efficacy of hydrocortisone replacement therapy in patients with partial cortisol deficiency after traumatic brain injury or subarachnoid hemorrhage on cognitive function.

NCT ID: NCT01088308 Terminated - Clinical trials for Arrhythmias, Cardiac

Hemodynamic Differentiation of Tachycardia Episodes Using Tissue Perfusion

Start date: March 2010
Phase: N/A
Study type: Interventional

This research study is a prospective, single-center, feasibility study designed to assess the possibility to detect hemodynamic changes during tachycardia episodes using tissue perfusion.

NCT ID: NCT01088256 Terminated - Clinical trials for Postherpetic Neuralgia

Efficacy of Etoricoxib on Peripheral Hyperalgesia

Start date: February 2011
Phase: Phase 2
Study type: Interventional

The purpose of the study is to determine the efficacy of etoricoxib on pain patients. The investigators assume that patients with neuropathic pain will have greater pain relief then patients on placebo.

NCT ID: NCT01084408 Terminated - Clinical trials for Coronary De-novo Stenoses

Efficacy of the SeQuent®Please in the Treatment of De-novo Stenoses Versus Taxus™Liberté™

PEPCAD-DEBonly
Start date: March 1, 2010
Phase: Phase 3
Study type: Interventional

The aim of the trial is to assess the efficacy of the Paclitaxel-coated SeQuent®Please angioplasty balloon in the treatment of stenoses in native coronary arteries compared to a drug eluting stent.